Emerald Therapeutics is categorized under X-Ray Equipment Manufacturers in Menlo Park, CA and active since 2010.
Emerald Therapeutics was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a X-Ray Equipment Manufacturers business, which does work in the B2B market, and is classified as a X-Ray Equipment Manufacturers, under code number 8121990 by the NAICS.
If you are seeking more information, feel free to contact Daniel Jerome Kleinbaum at the company’s single location by writing to 3475 Edison Way # M, Menlo Park, California CA 94025 or by phoning (650) 257-7554. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Emerald Therapeutics |
Contact Person: | Daniel Jerome Kleinbaum |
Address: | 3475 Edison Way # M, Menlo Park, California 94025 |
Phone Number: | (650) 257-7554 |
Website Address: | emeraldtherapeutics.com |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | X-Ray Equipment Manufacturers |
SIC Code: | 3844 |
NAICS Code: | 8121990 |
Share This Business: |
Emerald Therapeutics was started in 2010 to provide professional X-Ray Equipment Manufacturers under the SIC code 3844 and NAICS code 8121990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Daniel Jerome Kleinbaum for inquiries that concern Emerald Therapeutics by calling the company number (650) 257-7554, as your correspondence is most welcome. Additionally, the physical location of the single location of Emerald Therapeutics can be found at the coordinates 37.47598,-122.19722 as well as the street address 3475 Edison Way # M in Menlo Park, California 94025.
For its online presence, you may visit Emerald Therapeutics’s website at emeraldtherapeutics.com and engage with its social media outlets through on Twitter and on Facebook.